CLINICAL_TRIALS
trial_result
· 2019-11-04
Clinical Trial Update: Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001) [Phase 1]
Summary
Phase 1 trial of MK-1248 with and without pembrolizumab in participants with advanced solid tumors was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Advanced Solid Tumor | Phase 1 | Status: TERMINATED | Results posted: 2019-11-04